T
Tempest Therapeutics, Inc. (TPST)
NCM – Real vaqt narxi. Valyuta: USD
1.92
-0.02 (-1.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.92
-0.02 (-1.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Tempest Therapeutics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, saratonni davolash uchun kichik molekulali terapevtik vositalarni ishlab chiqadi. Uning asosiy mahsulot nomzodlari orasida Amezalpat, peroksizom proliferator bilan faollashadigan alfa retseptorining og'iz orqali qabul qilinadigan kichik molekulali selektiv antagonist, birinchi liniyali rezektsiya qilinmaydigan yoki metastatik gepatotsellyulyar karsinomani davolash uchun, 2-bosqichli klinik sinovni yakunlagan; va TPST-1495, prostaglandin E2 ning EP2 va EP4 retseptorlarining kichik molekulali er-xotin antagonist, turli saraton turlarini davolash uchun. Kompaniya Amezalpatni global birinchi liniyali randomizatsiyalangan tadqiqotga aylantirish uchun F. Hoffmann-La Roche Ltd. bilan hamkorlik shartnomasiga ega. Tempest Therapeutics, Inc. shtab-kvartirasi Brisben, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew Fang Ph.D. | Head of Business Development |
| Dr. Matthew Angel Ph.D. | President, CEO & Director |
| Mr. Justin Trojanowski CPA | Corporate Controller, Treasurer & Principal Accounting Officer |
| Mr. Nicholas Maestas | CFO, Head of Corporate Strategy & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 8-K | d93617d8k.htm |
| 2026-04-08 | CORRESP | filename1.htm |
| 2026-04-02 | S-3 | d17525ds3.htm |
| 2026-04-01 | CORRESP | filename1.htm |
| 2026-03-31 | S-8 POS | d90534ds8pos.htm |
| 2026-03-30 | S-3 | d104843ds3.htm |
| 2026-03-23 | 8-K | d85035d8k.htm |
| 2026-02-25 | 8-K | d22967d8k.htm |
| 2026-02-11 | 8-K | d47566d8k.htm |
| 2026-02-06 | 8-K | d159400d8k.htm |